ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1378	National Cancer Institute	Html	en	Childhood Brain Stem Glioma Treatment (PDQ®)–Health Professional Version	Diffuse intrinsic pontine glioma (DIPG) is a fast-growing childhood brain stem glioma that is difficult to treat and has a poor prognosis. A focal glioma grows more slowly, is easier to treat, and has a better prognosis. Learn about the diagnosis, cellular classification, staging, treatment, and clinical trials for pediatric brain stem glioma in this expert-reviewed summary.	corresponding treatment summary 0.689411 focal brainstem gliomas 0.801159 brain stem tumours 0.666641 diffuse brainstem gliomas 0.915552 adult high-grade gliomas 0.779058 brain tumors 0.871609 children 0.712329 histologic confirmation 0.674199 pediatric high-grade gliomas 0.777704 diffuse intrinsic brain 0.79588 clinical trials 0.703298 Tumors Treatment Overview 0.783812 H3 K27M mutation 0.767013 phase I/II study 0.654843 Primary tumors 0.67784 high-risk brainstem tumors 0.802443 World Health Organization 0.800016 brain stem tumors 0.783084 single new treatment 0.675971 brainstem gliomas 0.982733 specific H3 K27M 0.672189 common solid tumor 0.66912 radiation therapy 0.772489 intrinsic pontine glioma 0.876111 diffuse pontine gliomas 0.849232	Diffuse brainstem glioma 0.837788 et al. 0.72856 intrinsic brainstem gliomas 0.920288 childhood cancer mortality 0.676419 intrinsic pontine gliomas 0.828567 Glioma Cooperative Group 0.697725 brain tumor treatment 0.735178 brain stem gliomas 0.821857 3-dimensional conformal radiation therapy 0.714672 low-grade morphological characteristics 0.653573 Pediatr Blood Cancer 0.768008 paediatric pontine glioma 0.728445 diffuse intrinsic brainstem 0.904976 Primary brain tumors 0.784905 Abstract 0.747074 pediatric brain tumors 0.745588 nervous system tumors 0.673857 H3 K27M mutation. 0.670015 Clin Oncol 0.65677 childhood brain tumors 0.756852 newly diagnosed diffuse 0.79983 pediatric diffuse 0.708327 thalamic tumors 0.673454 midline high-grade gliomas 0.786516	CLICK HERE
1606	National Cancer Institute	Html	en	Esophageal Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for esophageal cancer.	cancer treatment 0.387405 ongoing clinical trials 0.392728 Esophageal cells 0.394141 following PDQ summaries 0.45401 PDQ cancer information 0.609599 false-negative test result 0.383414 cell esophageal cancer 0.474658 lower esophageal sphincter 0.425437 esophageal cancer screening 0.538472 clinical trials 0.540395 test result 0.424347 cancer information summary 0.521921 clinical trial 0.401913 risk factors 0.432802 breast cancer prevention 0.411928 false-positive test result 0.383086 cancer patients 0.381861 latest published information 0.3956 early Barrett esophagus 0.54548 NCI’s PDQ 0.405873 cancer symptoms 0.40272 NCI PDQ cancer 0.478991 tests 0.414709 esophageal adenocarcinoma 0.437047	PDQ Screening 0.430577 esophageal cancer 0.833194 screening tests 0.389343 esophageal cancer increases 0.474161 Cancer Information Service 0.428795 Prevention Editorial Board 0.449486 treatment clinical trials 0.391268 fewer new cases 0.389051 National Cancer Institute 0.535839 PDQ documents 0.397318 new treatment 0.396213 Cancer screening trials 0.467493 Cancer Care page 0.416248 PDQ database 0.401252 risk factor 0.382958 PDQ summary 0.423142 cancer information summaries 0.436287 health professional versions 0.379866 lining 0.379758 comprehensive cancer information 0.436148 cancer 0.985172 esophagus produce 0.441607 esophagus 0.633278 squamous cell carcinoma 0.55263	CLICK HERE
1722	National Cancer Institute	Html	en	Head and Neck Cancers	A fact sheet about the risk factors, symptoms, diagnosis, treatment, follow-up, and rehabilitation for cancers of the head and neck.	Neck Cancer Epidemiology 0.558891 cancer treatment 0.49699 Fraumeni JF Jr. 0.515344 ongoing clinical trials 0.479834 squamous cell cancers 0.517935 nasopharyngeal cancer 0.510884 paranasal sinuses 0.510171 aerodigestive tract cancers 0.489416 Finding NCI-Supported Clinical 0.476958 American Cancer Society 0.489371 Cancer Treatment Research 0.487757 clinical trials 0.625013 Epstein-Barr virus 0.482033 neck cancer regions 0.574118 risk factors 0.503876 neck cancers 0.925546 PDQ® cancer treatment 0.487339 human papillomavirus 0.505881 HPV-positive oropharyngeal cancer 0.487463 Cancer Epidemiology Consortium 0.490318 United States 0.527186 primary cancer 0.487797 especially cancers 0.493827 Cancer fact sheet 0.485173	oropharyngeal cancers 0.540233 cancer information specialist 0.512175 Cancer Information Service 0.478534 neck squamous cell 0.508691 head 0.661624 neck primary site 0.509523 nci-supported clinical trials 0.526157 Oxford University Press 0.514213 National Cancer Institute 0.552506 neck area 0.499808 nasal cavity 0.508976 salivary glands 0.562893 risk factor 0.525252 Neck Surgery 0.494318 information specialist online 0.474123 cancer clinical trials 0.537911 salivary gland cancer 0.527021 neck cancer 0.711277 Clinical Cancer Research 0.481823 et al 0.678713 oral cavity 0.564891 salivary gland cancers 0.553898 oropharyngeal cancer 0.508219 oropharyngeal cancer incidence 0.479853	CLICK HERE
1762	National Cancer Institute	Html	en	Access to Investigational Drugs	A fact sheet that defines investigational drugs (drugs under study but not yet FDA approved) and describes ways one might get access to these treatments.	NCI-designated cancer centers 0.38027 specific drug 0.365425 following criteria 0.380266 NCI program 0.360621 NCI’s Cancer 0.393319 case-by-case basis 0.385443 specific investigational drug 0.531382 FDA approval process 0.46336 NCI’s role 0.358363 TRC protocol 0.386712 Biologics License Application 0.383962 Institutional Review Board 0.372082 special exception programs 0.401115 investigational agent 0.482556 clinical trials 0.558265 specific criteria 0.382975 U.S. Food 0.350319 special exception mechanism 0.383615 clinical trial 0.636376 patients 0.498827 Special Exception/Compassionate Exemption 0.383931 access protocol 0.441767 drug development 0.379672 study sponsor 0.351362 Investigational New Drug 0.563996	FDA approval 0.502957 New Drug Application 0.4108 wide geographic availability 0.374872 NCI 0.425588 expanded access protocols 0.412645 IND 0.351277 investigational drug 0.866441 sponsor 0.450913 treatment 0.39466 access 0.446945 new drugs 0.396554 Drug Administration 0.379954 Cancer Information Service 0.448715 special exception 0.541023 compassionate exception 0.351227 investigational drugs 0.95169 patient 0.385651 appropriate reviewing division 0.371824 drug company 0.56293 expanded access protocol 0.400476 health insurance company 0.376702 CIS information specialists 0.382598 clinical trials database 0.391459 Treatment Referral Center 0.38112	CLICK HERE
1821	National Cancer Institute	Html	es	Tratamiento de los tumores neuroendocrinos de páncreas (tumores de células de los islotes) (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores neuroendocrinos de páncreas (tumores de células de los islotes).	Compton CC 0.337256 Hepatic arterial embolization 0.325449 Palliative cytoreductive surgery 0.324641 Surg Oncol Clin 0.345323 Institute Neuroendocrine Tumor 0.318293 cases with 0.339293 cytoreductive surgery versus 0.325381 Zee S 0.32021 from neuroendocrine tumors 0.335775 Curr Gastroenterol Rep 0.341683 metastatic pancreatic 0.328587 Sharma D 0.340566 7th ed 0.33713 neuroendocrine tumors after 0.325028 pancreatic endocrine neoplasms 0.343793 Pract Res Clin 0.325267 Prognostic factors 0.322876 Arch Surg 0.319413 Kulke MH 0.322635 peripancreatic neuroendocrine tumors 0.33552 patients with 0.809404 Davies K 0.320348 Database Syst Rev 0.362811 Conlon KC 0.392512 metastases from 0.336216	neuroendocrine tumors 0.991054 Cancer Institute Neuroendocrine 0.319181 Liver resection versus 0.326125 unresectable neuroendocrine hepatic 0.331365 neuroendocrine tumors uncontrolled 0.335147 Gurusamy KS 0.342295 Cancer Staging Manual 0.396035 tumores neuroendocrinos 0.382461 National Cancer Institute 0.337396 neuroendocrine tumours 0.357049 Radioembolization with 0.325231 Yao JC 0.326134 using resin 90Y-microspheres 0.325276 Kwekkeboom DJ 0.325065 New York 0.332728 internal radiation microspheres 0.324552 Clin Oncol 0.662006 Gastrointest Surg 0.319657 Hochwald SN 0.321828 Byrd DR 0.335399 pancreatic neuroendocrine tumors 0.490395 with pancreatic 0.327776 Res Clin Gastroenterol 0.325221 AJCC Cancer Staging 0.3987	CLICK HERE
1937	National Cancer Institute	Html	es	Tratamiento de los cánceres poco comunes en la niñez (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los cánceres poco comunes en la niñez como los cánceres de la cabeza y el cuello, el tórax, el abdomen, el aparato reproductor, la piel y otros.	glándula tiroides 0.938162 siguientes procedimientos 0.472657 posibles efectos tardíos 0.3766 hormona tiroidea 0.437118 color blanco plateado 0.323284 adultos jóvenes 0.322007 efectos secundarios meses 0.525317 faja ajustadora 0.360779 pequeña cantidad 0.416767 tratamiento causa 0.422854 células normales.ampliar exploración 0.550413 ecografía completa 0.326705 vía oral 0.351058 rayos x 0.35409 Masas indoloras 0.337566 niño ayuda 0.375685 efectos tardíos 0.809559 escáner.ampliar exploración 0.389789 PDQ Efectos tardíos 0.373896 vías respiratorias 0.465531	tarde.ampliar ecografía 0.364218 órgano fonador 0.316018 tumores benignos 0.352678 gen apc 0.327747 endocrina múltiple tipo 0.438625 PDQ Tratamiento 0.416786 área pequeña detrás 0.333456 gen nut 0.365005 siguientes problemas 0.361501 explorador tep 0.372891 siguientes signos 0.678578 nuevos tipos 0.336277 gen pten 0.328711 enfermedad.ampliar endoscopia 0.360667 linfocitos t 0.350025 hormona calcitonina 0.330174 células tiroideas 0.433364 toma imágenes 0.349043 Ojos saltones 0.331931	CLICK HERE
3445	National Cancer Institute	Html	es	Exámenes de detección del cáncer de cavidad oral y orofaringe (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de cavidad oral y orofaringe.	área pequeña detrás 0.683574 tratamiento causa efectos 0.644315 siguientes procedimientos 0.606927 Visuals Online 0.549544 PDQ Exámenes 0.703056 Physician Data Query 0.843474 prevención revisa 0.561244 siguientes tejidos 0.858513	PDQ Prevención 0.768143 cánceres ayuda 0.626832 información ayuda 0.565771 National Cancer Institute 0.586864 cáncer quizás 0.965609 siguientes riesgos 0.571803 siguientes sumarios 0.718231 Instituto Nacional 0.660842	CLICK HERE
3524	National Cancer Institute	Html	null	Planning for the Future—How NCI Gives Cancer Survivors Hope for a Family	NCI Story of Discovery portrays how fertility preservation research aids cancer survivors and supports families.			CLICK HERE
15653	National Cancer Institute	Html	en	Grant Closeout	Learn about the administrative actions and requirements to comply with grants closeout.	recipient institution 0.403385 current competitive segment 0.4584 Final Research Performance 0.470424 FRPPR 0.272101 Progress Report 0.292765 recipient organization 0.397988 business official 0.281485 Report Additional Materials 0.646337 new competitive segment 0.466064 Interim RPPR 0.480283 Final RPPR 0.617886 Guide Notice 0.494667 applicable administrative actions 0.459328 project period 0.315182 Process Final RPPR 0.451009 Closeout status screen 0.633167 federal government 0.280609 eRA Commons 0.988859 Final Report Additional 0.435922 additional information 0.556844 Guide Notice NOT-OD-17-037 0.449856	future funding 0.297581 Interim Report Additional 0.450898 IRPPR link 0.291974 IRPPR 0.302645 property accountability 0.290412 later refunds 0.280936 competitive segment 0.500951 grant closeout process 0.873148 closeout documentation 0.730869 current annual RPPR 0.439246 financial accountability 0.290106 Unilateral Closeout action 0.746529 Signing Official 0.282197 grant support 0.576328 additional information online 0.441695 record retention 0.281581 renewal application 0.63575 new institution 0.307358 program directors 0.303803 grant closeout reports 0.857404 submission 0.258668	CLICK HERE
17171	National Cancer Institute	Html	es	PC-SPES (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de PC-SPES como tratamiento del cáncer de próstata. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	médico herborista 0.418438 Centro Nacional 0.430037 New Hampshire Avenue 0.420405 Drug Administration 0.412734 NCI Best Case 0.437012 datos bibliográficos pubmed 0.422243 siguientes preguntas 0.413766 demostró efectos 0.424258 siguientes riesgos 0.417668 seguro médico 0.412292 múltiples problemas 0.418438 Instituto Nacional 0.517971 acupuntura ayuda 0.412243 Salud Complementaria 0.450225 Visuals Online 0.415643	complementarias revisa 0.422417 Physician Data Query 0.491682 Estados Unidos 0.863449 actúa pc-spes 0.442835 libre uso 0.415953 suficiente cantidad 0.41905 página manejo 0.414584 ¿El tratamiento 0.421322 Nueva York 0.418373 ¿Los beneficios 0.413162 siguientes medicamentos 0.438285 Series Program 0.413051 medicina complementaria 0.925538 diferentes lotes 0.423892	CLICK HERE